Stay updated on ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer
Sign up to get notified when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.

Latest updates to the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe history now shows a new site revision (v3.6.4) replacing the previous revision (v3.6.3), indicating a recent software release for the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new Study Status entry was added to the record history (noted on 2026-07-02 with 120 items) and an older entry dated 2026-06-05 was removed. This updates the visible history of the trial’s status and its historical record.SummaryDifference0.1%

- Check33 days agoChange DetectedThe record history now shows the page revision updated to v3.6.3, replacing the previous v3.6.2, reflecting an underlying platform update rather than changes to study content.SummaryDifference0.0%

- Check39 days agoChange DetectedFooter now displays Revision: v3.6.2, replacing v3.6.0. This indicates a recent software update applied to the page.SummaryDifference0.0%

- Check54 days agoChange DetectedOne addition indicates the study is no longer looking for participants, signaling that recruitment has ceased. The record history also shows a new revision tag v3.6.0 and the removal of the previous v3.5.5 revision, reflecting an update to the study documentation.SummaryDifference0.1%

- Check61 days agoChange DetectedThe history now includes a new revision tag, v3.5.5, indicating a minor site update. It replaces the previous v3.5.4 revision.SummaryDifference0.0%

Stay in the know with updates to ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.